SecBot SecBot
Insider Cluster (4 insiders) ·Filed May 19, 2026

PCSA

Processa Pharmaceuticals, Inc.
BULLISH
Impact 5/10
Horizonweeks Processed5mo ago
Insider cluster: 4 insiders, $0.0M total
Actionable Insight ▲ Bullish

Monitor for upcoming catalysts such as clinical trial updates or financing announcements that may have prompted insider buying. Given the micro-cap nature and low liquidity, position sizing should be cautious. Consider following the insider signal with a stop-loss below recent support.

DirectionBullish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
PCSA ▼ -6.90% at T+60d
LONG call ✗ call lost -6.90% · α vs SPY -11.90% · entry $2.61 → $2.43
Entry = T+0 close
May 19, 2026
via day close
T+1d
-1.72%
call -1.72% · α -1.92%
$2.57
settled 5mo ago
T+5d
+1.15%
call +1.15% · α -0.65%
$2.64
settled 5mo ago
T+20d
-18.77%
call -18.77% · α -19.51%
$2.12
settled 4mo ago
T+60d
-6.90%
call -6.90% · α -11.90%
$2.43
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Four C-suite insiders at Processa Pharmaceuticals (PCSA) collectively purchased $19K worth of shares on May 15, 2026, at $2.97 per share. This cluster buying represents 0.24% of the $8M market cap and is a modest but notable bullish signal given the CFO and other top executives are investing personal capital.

Key Financial Metrics

Direction
buying
Total Value
$19.0K
Insiders
4

Key Facts

  • CFO Russell Skibsted, President of R&D David Young, CAO Wendy Guy, and Chief Business Strategy Officer Patrick Lin all bought shares on May 15, 2026.
  • Total insider purchases amount to approximately $19,000, or 0.24% of market cap.
  • All transactions were open-market buys at $2.97 per share.
  • No insider sales were reported in the cluster period.

Financial Impact

Approximately $19,000 in insider purchases, representing 0.24% of the $8M market cap.

insider holdings

Risk Factors

  • Micro-cap stock with low liquidity and high volatility.
  • Insider cluster buys, while positive, do not guarantee short-term price appreciation.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PCSA-1779228307272
14 reports for PCSA
Performance horizon
60% Hit rate @ T+5 6 of 10 directional calls Went positive at some point 8 of 10 best @ T+5▲ +19.60%Mar 31, 2026
Filters
Rows
Reports for PCSA — sortable, filterable
TypeNow
Oct 26, 2026
today
EFFECT
BEARISH ★ 6/10
$1.81awaiting T+5—$1.79 (+0.83%)
Oct 22, 2026
4d ago
DEF 14A
NEUTRAL ★ 4/10
$1.81awaiting T+5—$1.79 (−0.83%)
Oct 9, 2026
17d ago
S-3
BEARISH ★ 7/10
$1.90 $1.73▲ +8.95%▲ +7.45%$1.79 (+5.53%)
Jul 29, 2026
12w ago
8-K
MIXED ★ 6/10
$2.03 $2.19▲ +7.88%▲ +2.35%$1.79 (−11.58%)
Jul 1, 2026
16w ago
Insider Cluster
BULLISH ★ 5/10
$2.16 $2.16· 0.00%▼ −1.37%$1.79 (−16.90%)
Jun 16, 2026
18w ago
Insider Cluster
BULLISH ★ 5/10
$2.15 $1.93▼ −10.23%▼ −9.19%$1.79 (−16.51%)
Jun 16, 2026
18w ago
Insider Cluster
BULLISH ★ 4/10
$2.15 $1.93▼ −10.23%▼ −9.19%$1.79 (−16.51%)
Jun 1, 2026
21w ago
Insider Cluster
BULLISH ★ 4/10
$2.92 $2.04▼ −30.31%▼ −27.34%$1.79 (−38.53%)
May 19, 2026
22w ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.64▲ +1.15%▼ −0.65%$1.79 (−31.23%)
May 19, 2026
22w ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.64▲ +1.15%▼ −0.65%$1.79 (−31.23%)
Showing 10 of 14

US Market Status

Market Closed — Opens Wed (10h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 19, 2026